MIPL - CARDIAC SCREENING PLUS
MRP - ₹ 15,270 10,600
About the package:
The Cardiac Screening Panel Plus is an advanced, all-in-one diagnostic package for a complete heart health evaluation. It combines detailed laboratory analysis with cardiac and vascular imaging to assess diabetes control, lipid imbalances, inflammation, advanced cardiovascular risk markers, kidney function, and early signs of vascular damage. The package also evaluates heart structure, valve performance, pumping efficiency, electrical activity, rhythm, and neck artery health to detect risks for coronary artery disease, heart attack, stroke, and atherosclerosis. This enhanced screening is particularly important for women, who face unique heart health challenges. Heart disease is their number one killer, yet it frequently goes unnoticed due to subtler or atypical symptoms, smaller arteries, hormonal changes after menopause, pregnancy-related complications, autoimmune influences, and greater susceptibility to silent progression. Early comprehensive assessment empowers better prevention and improved long-term heart health outcomes.
Additional Information
| Tests: | LIPID PROFILE BASIC, KIDNEY PANEL KFT BASIC, HbA1c GLYCOSYLATED HEMOGLOBIN, GLUCOSE FASTING (F), URINE EXAMINATION R/M, Echocardiography, ECG, MICROALBUMIN 1ST MORNING / RANDOM URINE, HIGH SENSITIVITY C-REACTIVE PROTEIN CARDIO; HsCRP, HOMOCYSTEINE QUANTITATIVE SERUM, APOLIPOPROTEINS A1 & B, DOPPLER CAROTID, LIPOPROTEIN (A); Lp(a) |
| Parameters: | 48 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood, Urine |
| Patient Preparation: | 1. Complete 4 hours of fasting (plain water allowed). 2. Bathe before reporting, and male patients with a hairy chest should shave. 3. Carry your prescription, previous records if any, and have one attendant accompany you. |
| Reports: | 24 working hours |
| Purpose: | To comprehensively assess advanced cardiovascular risks, heart structure, and function, enabling early prevention of heart disease and stroke |
FAQs
An ECHO images heart structure, valves, pumping strength; while ECG checks electrical rhythm/arrhythmias—together they reveal structural/functional issues not caught by blood tests alone.
The standard lipids measure cholesterol/triglycerides; while Apo A1/B provide a more precise count of atherogenic (plaque-causing) particles — ApoB is often a better predictor of heart risk than LDL alone.
Lp(a) is a genetic, sticky form of LDL cholesterol that promotes plaque and clots; high levels (largely inherited) raise heart disease/stroke risk independently of lifestyle.
Elevated homocysteine (an amino acid) damages artery walls and increases clotting risk; high levels link to higher chances of heart attack, stroke, or vessel disease.
Heart disease is the leading cause of death in women, often with subtler symptoms; unique risks (menopause, pregnancy history, autoimmune factors) make early, advanced screening crucial for prevention.
